Eli Lilly Total Liabilities 2010-2025 | LLY

Eli Lilly total liabilities for the quarter ending March 31, 2025 were $64.443B, a 21.26% increase year-over-year.

  • Eli Lilly total liabilities for 2024 were $64.443B, a 21.26% increase from 2023.
  • Eli Lilly total liabilities for 2023 were $53.143B, a 37.27% increase from 2022.
  • Eli Lilly total liabilities for 2022 were $38.714B, a 2.36% decline from 2021.

Eli Lilly Total Liabilities 2010-2025 | LLY

  • Eli Lilly total liabilities for 2024 were $64.443B, a 21.26% increase from 2023.
  • Eli Lilly total liabilities for 2023 were $53.143B, a 37.27% increase from 2022.
  • Eli Lilly total liabilities for 2022 were $38.714B, a 2.36% decline from 2021.
Related Stocks
Company NameMarket
Cap
Johnson & Johnson (JNJ)$379.5B
AbbVie (ABBV)$306B
Novo Nordisk (NVO)$260.6B
Roche Holding AG (RHHBY)$248.1B
Novartis AG (NVS)$234.2B
Merck (MRK)$196.7B
Sanofi (SNY)$128.6B
Pfizer (PFE)$125.6B
Bayer (BAYRY)$23.7B
Innoviva (INVA)$1.1B